SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-15-020027
Filing Date
2015-11-06
Accepted
2015-11-06 15:09:22
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bota20150930_10q.htm 10-Q 787611
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 19113
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 18917
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 12868
  Complete submission text file 0001437749-15-020027.txt   3528894

Data Files

Seq Description Document Type Size
5 EXHIBIT 101.INS bota-20150930.xml EX-101.INS 727592
6 EXHIBIT 101.SCH bota-20150930.xsd EX-101.SCH 32092
7 EXHIBIT 101.CAL bota-20150930_cal.xml EX-101.CAL 29634
8 EXHIBIT 101.DEF bota-20150930_def.xml EX-101.DEF 200703
9 EXHIBIT 101.LAB bota-20150930_lab.xml EX-101.LAB 200673
10 EXHIBIT 101.PRE bota-20150930_pre.xml EX-101.PRE 221454
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 151205515
SIC: 2836 Biological Products, (No Diagnostic Substances)